Camilla Genovese

473 total citations
16 papers, 53 citations indexed

About

Camilla Genovese is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Camilla Genovese has authored 16 papers receiving a total of 53 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 6 papers in Epidemiology and 4 papers in Pharmacology. Recurrent topics in Camilla Genovese's work include Central Venous Catheters and Hemodialysis (4 papers), COVID-19 Clinical Research Studies (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Camilla Genovese is often cited by papers focused on Central Venous Catheters and Hemodialysis (4 papers), COVID-19 Clinical Research Studies (3 papers) and Antibiotic Resistance in Bacteria (3 papers). Camilla Genovese collaborates with scholars based in Italy, Netherlands and Denmark. Camilla Genovese's co-authors include Andrea Gori, Marta Colaneri, Lucia Galli, Stefania Merli, Riccardo De Giorgi, Andrea Lombardi, Dario Cattaneo, Emanuele Maria Giusti, Alessandra Bandera and Antonio Muscatello and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology and Clinical Microbiology and Infection.

In The Last Decade

Camilla Genovese

10 papers receiving 53 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Camilla Genovese Italy	6	37	15	9	9	8	16	53
Güle Çınar Türkiye	5	37 1.0×	8 0.5×	26 2.9×	3 0.3×	8 1.0×	28	77
Benjamin Viala Switzerland	6	32 0.9×	13 0.9×	9 1.0×	12 1.3×	20 2.5×	10	71
Tuba Vilken Belgium	4	29 0.8×	9 0.6×	17 1.9×	8 0.9×	10 1.3×	6	54
Gerardo León-Garnica Mexico	6	27 0.7×	11 0.7×	11 1.2×	11 1.2×	14 1.8×	9	61
Filomena Boccia Italy	4	45 1.2×	10 0.7×	24 2.7×	8 0.9×	37 4.6×	10	81
Mbiye Mpenge United Kingdom	2	15 0.4×	11 0.7×	6 0.7×	7 0.8×	3 0.4×	2	28
Sheila Cárcel Spain	3	20 0.5×	6 0.4×	6 0.7×	2 0.2×	13 1.6×	3	54
Ana C. Bardossy United States	5	24 0.6×	7 0.5×	16 1.8×	22 2.4×	22 2.8×	10	65
Yaneicy Gonzalez‐Rojas United States	2	74 2.0×	21 1.4×	24 2.7×	13 1.4×	10 1.3×	2	111
Aline Munting Switzerland	4	15 0.4×	7 0.5×	19 2.1×	11 1.2×	14 1.8×	12	46

Countries citing papers authored by Camilla Genovese

Since Specialization

Citations

This map shows the geographic impact of Camilla Genovese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Genovese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Genovese more than expected).

Fields of papers citing papers by Camilla Genovese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camilla Genovese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Genovese. The network helps show where Camilla Genovese may publish in the future.

Co-authorship network of co-authors of Camilla Genovese

This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Genovese. A scholar is included among the top collaborators of Camilla Genovese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Genovese. Camilla Genovese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Colaneri, Marta, Lucia Galli, Camilla Genovese, et al.. (2025). The CONSIDER study: Assessing the risk of catheter-associated bloodstream infections beyond the intensive care setting. American Journal of Infection Control. 53(9). 950–956.

Colaneri, Marta, Lucia Galli, Giovanni Luca Scaglione, et al.. (2025). Vascular Access Device Infections: Current Management Practices and the Role of Multidisciplinary Teams at a Large Hospital in Northern Italy. Antibiotics. 14(1). 27–27.

Genovese, Camilla, Marta Colaneri, Marta Colaneri, et al.. (2025). Hospital Acquired Infections Among Solid Organ Transplant Recipients Hospitalized in Intensive Care Unit (2018–2024): A Study of the GiViTI Group. Transplant Infectious Disease. 27(6). e70120–e70120.

Colaneri, Marta, Giorgia Montrucchio, Giovanni Luca Scaglione, et al.. (2025). Incidence, microbiology, and mortality of ventilation-associated pneumonia in a large Italian cohort of critically ill patients: results from the PROSAFE project. Clinical Microbiology and Infection. 31(9). 1491–1499.

Piscaglia, Marco, Camilla Genovese, Renata Grifantini, et al.. (2025). Exploring Human Use of Monoclonal Antibodies Against Critical Bacteria: A Scoping Review of Clinical Trials. Infectious Diseases and Therapy. 14(8). 1619–1647. 1 indexed citations

Genovese, Camilla, Giovanni Luca Scaglione, Emanuele Palomba, et al.. (2025). P-229. Epidemiology of Catheter-Related Bloodstream Infections in Italian Intensive Care Units: Data from the Italian Network for the Evaluation of ICU Interventions. Open Forum Infectious Diseases. 12(Supplement_1).

Scaglione, Giovanni Luca, Marta Colaneri, Lucia Galli, et al.. (2024). Epidemiology and Clinical Insights of Catheter-Related Candidemia in Non-ICU Patients with Vascular Access Devices. Microorganisms. 12(8). 1597–1597. 1 indexed citations

Scaglione, Giovanni Luca, Marta Colaneri, Camilla Genovese, et al.. (2024). Understanding the burden of antibiotic resistance: a decade of carbapenem-resistant Gram-negative bacterial infections in Italian intensive care units. Frontiers in Microbiology. 15. 1405390–1405390. 5 indexed citations

Colaneri, Marta, Camilla Genovese, Marta Canuti, et al.. (2024). Prognostic Significance of NLR and PLR in COVID-19: A Multi-Cohort Validation Study. Infectious Diseases and Therapy. 13(5). 1147–1157. 6 indexed citations

10.

Colaneri, Marta, et al.. (2024). Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice. European Journal of Clinical Microbiology & Infectious Diseases. 43(5). 1017–1023.

11.

Cattaneo, Dario, Lucia Galli, Camilla Genovese, et al.. (2024). Proactive therapeutic monitoring of dalbavancin concentrations in the long-term management of chronic osteoarticular/periprosthetic joint infections. Antimicrobial Agents and Chemotherapy. 68(4). e0002324–e0002324. 10 indexed citations

12.

Cattaneo, Dario, Marta Colaneri, Camilla Genovese, et al.. (2023). Therapeutic Drug Monitoring of Dalbavancin in Real Life: A Two-Year Experience. Antibiotics. 13(1). 20–20. 8 indexed citations

13.

Colaneri, Marta, Emanuele Maria Giusti, Camilla Genovese, et al.. (2023). Mortality of Patients With Candidemia and COVID-19: A Systematic Review With Meta-analysis. Open Forum Infectious Diseases. 10(7). ofad358–ofad358. 11 indexed citations

14.

Genovese, Camilla, et al.. (2023). Drug resistant tuberculosis in Italy through a global health lens.. PubMed. 46(2). 120–132. 1 indexed citations

15.

Biscarini, Simona, Simone Villa, Camilla Genovese, et al.. (2022). Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study. Biomedicines. 10(8). 2002–2002. 7 indexed citations

16.

Tanzi, Elisabetta, et al.. (2021). COVID-19 VACCINES: EVIDENCE, CHALLENGES AND THE FUTURE. PubMed. 62(1 Suppl 3). E18–E29. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact